Login
$LLY
$1,284.88 +$5.74 (0.45%) Live

$LLY 3/A SEC Filings

Filed On Filing
04 Sep 2026 Form 3/A: Brown Adrienne S, EVP, President LLY Imm

Holds 7,045.237 shares of Common Stock

03 Apr 2023 Form 3/A: Hedley Mary Lynne, Director

Holds 248 shares of Common Stock

07 Oct 2020 Form 3/A: Yuffa Ilya, SVP and Pres, Lilly Bio-Meds

Holds 6,813 shares of Common Stock

06 Feb 2019 Form 3/A: O'Neill Myles, SVP & Pres., Mfg. Operations
24 Sep 2018 Form 3/A: O'Neill Myles, SVP & Pres., Mfg. Operations
17 Jan 2018 Form 3/A: Shah Aarti S., SVP & CIO

Holds 12,841 shares of Common Stock

14 Apr 2016 Form 3/A: Lilly Eli & Co, 10% owner and 2 others · Spyre Therapeutics Inc

Holds 57,619 shares of Common Stock

21 May 2014 Form 3/A: Tai Jackson P, Director

Holds 2,235 shares of Common Stock

21 Nov 2013 Form 3/A: Lilly Eli & Co, 10% owner and 2 others · Receptos, Inc.

Holds 2,081,210 shares of Common Stock

04 Jun 2010 Form 3/A: Rice Derica W, EVP-Global Services and CFO

Holds 12,420 shares of Common Stock

27 Jan 2010 Form 3/A: Carmine Bryce D., EVP and Pres, Est Markets BU

Holds 40,136 shares of Common Stock

12 Nov 2009 Form 3/A: Mahony Susan, Senior VP, Human Resources
19 Jul 2005 Form 3/A: Murphy Anthony John, Senior VP, Human Resources

Holds 14,217 shares of Common Stock

24 Mar 2005 Form 3/A: Connelly Deirdre P, Senior VP, Human Resources

Holds 50 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support